alpha-methylacyl-CoA racemase ; Homo sapiens






100 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 9803880 New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders. Verh K Acad Geneeskd Belg 1998 1
2 10709653 Role and organization of peroxisomal beta-oxidation. Adv Exp Med Biol 1999 2
3 11060359 Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 2000 Nov 6
4 11160375 Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal alpha-methylacyl-CoA racemase deficiency. J Lipid Res 2001 Jan 5
5 11861706 A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry 2002 Mar 2
6 11893780 Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders. J Lipid Res 2002 Mar 1
7 11956072 Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002 Apr 15 1
8 11964182 The role of alpha-methylacyl-CoA racemase in bile acid synthesis. Biochem J 2002 May 1 1
9 12131161 Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 2002 Jul 4
10 12512044 Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology 2003 Jan 2
11 12673556 Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Hum Pathol 2003 Mar 2
12 12917210 Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev 2003 Aug 5
13 14506641 Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases. Hum Pathol 2003 Aug 2
14 14612535 Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 2003 Nov 1 4
15 14642549 A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev 2003 2
16 14982833 Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer. Am J Pathol 2004 Mar 2
17 15043314 How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 2004 Feb 1
18 15173267 Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst 2004 Jun 2 2
19 15599942 Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer. Prostate 2005 Jun 1 3
20 15632186 Alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis. Mutational and structural characterization of the active site and the fold. J Biol Chem 2005 Apr 1 3
21 15712232 Serum levels of phytanic acid are associated with prostate cancer risk. Prostate 2005 May 15 3
22 15755877 A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer. Mol Cancer Res 2005 Feb 2
23 15941950 Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev 2005 Jun 2
24 16082251 Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer. Appl Immunohistochem Mol Morphol 2005 Sep 4
25 16315020 Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 2006 Mar 1
26 16563090 Phytanic acid, AMACR and prostate cancer risk. Future Oncol 2006 Apr 2
27 16681682 Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy. Histopathology 2006 May 2
28 16819330 AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol 2006 Jul 1
29 16996568 Expression of alpha-methylacyl-coenzyme A racemase in dysplastic Barrett's epithelium. Hum Pathol 2006 Dec 2
30 17442371 Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Hum Pathol 2007 Jun 1
31 17477519 Design, synthesis, and in vitro testing of alpha-methylacyl-CoA racemase inhibitors. J Med Chem 2007 May 31 1
32 17525630 Alpha-methylacyl-CoA racemase/P504S overexpression in colorectal carcinoma is correlated with tumor differentiation. Appl Immunohistochem Mol Morphol 2007 Jun 2
33 17652945 Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach. Oncology 2006 4
34 17680641 Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. Prostate 2007 Oct 1 6
35 17684125 Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2007 Aug 6
36 17867650 Method for quantification of a prostate cancer biomarker in urine without sample preparation. Anal Chem 2007 Oct 15 1
37 17922592 Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis. Arch Pathol Lab Med 2007 Oct 2
38 17956237 Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review. Biochem Soc Trans 2007 Nov 2
39 18032455 Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency. J Neurol Neurosurg Psychiatry 2008 Apr 2
40 18080842 Molecular cloning and preliminary analysis of the human alpha-methylacyl-CoA racemase promoter. Mol Biol Rep 2009 Mar 4
41 18279392 Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage. FEBS J 2008 Mar 3
42 18648853 Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer. Virchows Arch 2008 Aug 2
43 18665038 p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus. Appl Immunohistochem Mol Morphol 2008 Oct 1
44 18712414 AMACR expression in colorectal cancer is associated with left-sided tumor localization. Virchows Arch 2008 Sep 5
45 18787636 Alpha-methylacyl-CoA racemase expression is upregulated in gastric adenocarcinoma: a study of 249 cases. Int J Clin Exp Pathol 2008 Apr 10 2
46 19596919 Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression. Anticancer Res 2009 Jul 2
47 19638170 Expression of alpha-methylacyl-CoA racemase (P504S) in sebaceous neoplasms. J Cutan Pathol 2010 Apr 4
48 19730362 Revisiting the immunophenotype of nephrogenic adenoma. Am J Surg Pathol 2009 Nov 1
49 20003233 Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer. J Transl Med 2009 Dec 9 4
50 20388135 Phytanic acid--an overlooked bioactive fatty acid in dairy fat? Ann N Y Acad Sci 2010 Mar 1